Achim Berthele

机构：TUM Klinikum, Technical University of Munich · ORCID：0000-0001-9650-6222

发表论文 388 篇 · 总被引 22803 次 · h-index 65

代表论文

• Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD (2024 · Journal of Neurology Neurosurgery & Psychiatry · 被引 30)
• Long-Term Treatment With Ocrelizumab in Patients With Early-Stage Relapsing MS (2025 · Neurology · 被引 28)
• Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease (2025 · JAMA Neurology · 被引 13)
• Large-scale proteomics across neurological disorders uncovers biomarker panel and targets in multiple sclerosis (2026 · Cell · 被引 9)
• Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study) (2025 · Frontiers in Immunology · 被引 8)
• Rituximab as First‐Line Compared to Escalation Immunotherapy Is Associated With Lower Disability Accumulation in Aquaporin‐4‐ IgG ‐Positive Neuromyelitis Optica Spectrum Disorder: A Multicenter Cohort Study From Germany and the United Kingdom (2025 · European Journal of Neurology · 被引 6)